Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?

Sankar K, Stein BL.

J Natl Compr Canc Netw. 2018 Dec;16(12):1539-1545. doi: 10.6004/jnccn.2018.7073. Review.

PMID:
30545998
2.

Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.

Boklan JL, Walsh AM, de la Maza MC, Su LL, Nizzi FA Jr, Schafernak KT.

J Pediatr Hematol Oncol. 2018 Aug;40(6):456-457. doi: 10.1097/MPH.0000000000001154.

PMID:
29668550
3.

How to Treat Essential Thrombocythemia and Polycythemia Vera.

Besses C, Alvarez-Larrán A.

Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S114-23. doi: 10.1016/j.clml.2016.02.029. Review.

PMID:
27521307
4.

Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up.

Pagnano KB, Delamain MT, Magnus MM, Vassallo J, DE Souza CA, DE Almeida D, Lorand-Metze I.

Oncol Lett. 2016 Jul;12(1):485-487. Epub 2016 May 26.

5.

CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation.

Bonzheim I, Mankel B, Klapthor P, Schmidt J, Hinrichsen T, Wachter O, Fend F, Quintanilla-Martinez L.

Blood. 2015 Apr 2;125(14):2309-11. doi: 10.1182/blood-2014-12-616847. No abstract available.

6.

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

Agarwal MB, Malhotra H, Chakrabarti P, Varma N, Mathews V, Bhattacharyya J, Seth T, Gayathri K, Menon H, Subramanian PG, Sharma A, Bhattacharyya M, Mehta J, Vaid AK, Shah S, Aggarwal S, Gogoi PK, Nair R, Agarwal U, Varma S, Prasad SV, Manipadam MT.

Indian J Med Paediatr Oncol. 2015 Jan-Mar;36(1):3-16. doi: 10.4103/0971-5851.151770.

7.

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.

Tefferi A, Barbui T.

Am J Hematol. 2015 Feb;90(2):162-73. doi: 10.1002/ajh.23895. Review. Erratum in: Am J Hematol. 2015 Sep;90(9):849.

8.

Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.

Lussana F, Rambaldi A, Finazzi MC, van Biezen A, Scholten M, Oldani E, Carobbio A, Iacobelli S, Finke J, Nagler A, Volin L, Lamy T, Arnold R, Mohty M, Michallet M, de Witte T, Olavarria E, Kröger N.

Haematologica. 2014 May;99(5):916-21. doi: 10.3324/haematol.2013.094284. Epub 2014 Jan 3.

9.

Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia.

Grisouard J, Ojeda-Uribe M, Looser R, Hao-Shen H, Lundberg P, Duek A, Jeandidier E, Karow A, Skoda RC.

Blood. 2013 Nov 21;122(22):3694-6. doi: 10.1182/blood-2013-07-516385. No abstract available.

10.

A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?

Hasselbalch HC.

Leuk Res. 2014 Feb;38(2):263-6. doi: 10.1016/j.leukres.2013.07.002. Epub 2013 Aug 9.

PMID:
23932394
11.
12.

[Treatment of essential thrombocythemia].

Alvarez-Larrán A, Cervantes F, Besses C.

Med Clin (Barc). 2013 Sep 21;141(6):260-4. doi: 10.1016/j.medcli.2013.01.016. Epub 2013 Mar 13. Review. Spanish.

PMID:
23490491
13.

Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.

Tefferi A.

Am J Hematol. 2012 Mar;87(3):285-93. doi: 10.1002/ajh.23135. Review.

14.

Occurrence of BCR-ABL1-positive chronic myeloid leukemia following essential thrombocythemia.

Weng WH, Shih LY.

Acta Haematol. 2011;126(4):220-3. doi: 10.1159/000330524. Epub 2011 Sep 20. No abstract available.

PMID:
21934297
15.

The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.

Abdulkarim K, Ridell B, Johansson P, Kutti J, Safai-Kutti S, Andréasson B.

Eur J Haematol. 2011 Feb;86(2):148-55. doi: 10.1111/j.1600-0609.2010.01548.x. Epub 2010 Dec 22.

PMID:
21059102
17.

Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.

Musolino C, Allegra A, Penna G, Centorrino R, Cuzzola M, D'Angelo A, Iacopino P, Alonci A.

Acta Haematol. 2009;122(1):46-9. doi: 10.1159/000243721. Epub 2009 Oct 7.

PMID:
19816006
18.

Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?

Tabaczewski P, Nadesan S, Lim SH.

Leuk Res. 2009 Jun;33(6):854-5. doi: 10.1016/j.leukres.2008.09.002. Epub 2008 Oct 11.

19.

Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation.

Hattori N, Fukuchi K, Nakashima H, Maeda T, Adachi D, Saito B, Yanagisawa K, Matsuda I, Nakamaki T, Gomi K, Tomoyasu S.

Int J Hematol. 2008 Sep;88(2):181-188. doi: 10.1007/s12185-008-0129-9. Epub 2008 Jul 10.

PMID:
18612778
20.

Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.

Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Björkholm M.

Blood. 2008 Sep 15;112(6):2199-204. doi: 10.1182/blood-2008-03-143602. Epub 2008 May 1.

Supplemental Content

Loading ...
Support Center